脳腫瘍診断および治療市場、規模、シェア、動向、産業分析レポート：タイプ別、製品別、診断別、治療別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、世界の脳腫瘍診断および治療市場規模は2034年までに65億972万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

脳腫瘍診断および治療市場は、脳内の腫瘍性増殖の同定と治療を目的とした医療技術と医薬介入の開発と展開を中心としています。この市場を牽引しているのは、良性から悪性度の高いものまで様々な脳腫瘍がもたらす複雑な診断と治療の課題に対処する必要性です。患者の転帰と生活の質を改善するために、高度な画像診断技術、洗練された臨床検査診断、革新的な治療法を統合した多面的なアプローチが必要です。この市場には、神経画像診断装置、分子診断ツール、手術装置、放射線治療システム、薬物療法など、患者やヘルスケアプロバイダーの多様なニーズを反映した幅広い製品とサービスが含まれています。

この市場を分析すると、急速な技術進歩と進化する治療パラダイムを特徴とする状況が明らかになります。脳腫瘍の有病率の増加は、高齢者人口の増加と相まって、大きな市場促進要因となっています。現在進行中の研究開発は、診断精度の向上、標的療法の開発、患者の生存率の改善に重点を置いています。ゲノミクスとプロテオミクスの進歩に後押しされた個別化医療アプローチの採用は、治療戦略に変革をもたらしつつあります。さらに、画像診断とデータ分析における人工知能と機械学習の統合は、臨床的意思決定の効率と精度を高めています。脳腫瘍診断・治療市場は、こうした課題と闘うための革新的ソリューションのあくなき追求によって、継続的な成長が見込まれています。

脳腫瘍診断および治療市場レポートハイライト

タイプ別では、神経膠腫や髄膜腫のような腫瘍の発生率が高く、広範な診断と治療介入が必要なプライマリーセグメンテーションが最大の市場シェアを占めています。

製品別では、脳腫瘍の診断と分類に不可欠な組織学的および免疫組織化学的手順において重要な役割を果たすステイン＆ワニス部門が最大の市場シェアを占めています。

診断別では、MRI分野が市場をリードしています。これは、その非侵襲的な性質と優れた高解像度画像処理能力によるもので、腫瘍の正確な位置特定と特徴付けに不可欠です。

治療別では、外科手術が最大の市場シェアを維持しているが、これは腫瘍摘出における基本的な役割、特にアクセスしやすく境界明瞭な腫瘍に対する基本的な介入戦略によるものです。

最終用途別では、病院部門が最大の市場シェアを占めています。これは、病院が総合的なケアを提供し、一つ屋根の下で幅広い診断・治療サービスを包含しているため、一次ケアの提供者となっていることによる。

地域別では、北米が世界市場で最大のシェアを占めているが、これは医療インフラが整備されており、脳腫瘍の有病率が高いためです。アジア太平洋地域は、老人人口の増加、脳腫瘍に対する意識の高まり、医療アクセスの改善により、最も高い成長率を示しています。

同市場で事業を展開する主要企業には、Hoffmann-La Roche AG、Novartis AG、Merck &Co., Inc.、Pfizer Inc.、Bristol Myers Squibb Company、Siemens Healthineers AG、GEヘルスケア（General Electric Company）、キヤノンメディカルシステムズ株式会社、Carl Zeiss Meditec AG、Intuitive Surgical, Inc.、株式会社日立製作所などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の脳腫瘍診断および治療市場の洞察

• 周波数スナップショット
• 脳腫瘍診断および治療市場力学
  • 促進要因と機会
    • 神経画像技術の進歩
    • 脳腫瘍の増加と人口の高齢化
  • 抑制要因と課題
    • 早期発見の難しさ
• PESTEL分析
• 脳腫瘍診断および治療の市場動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の脳腫瘍診断および治療市場：タイプ別

• 主な調査結果
• イントロダクション
• 一次
• 二次

第6章 世界の脳腫瘍診断および治療市場：製品別

• 主な調査結果
• イントロダクション
• ステインとニス
• シェラック
• ラッカー
• その他

第7章 世界の脳腫瘍診断および治療市場：診断別

• 主な調査結果
• イントロダクション
• MRI
• CTスキャン
• 組織サンプル採取
• PET-CTスキャン
• 脳動脈造影
• 腰椎穿刺
• 分子検査
• 脳波
• その他

第8章 世界の脳腫瘍診断および治療市場：治療別

• 主な調査結果
• イントロダクション
• 手術
• 放射線治療
• 化学療法
• 免疫療法
• 標的療法
• その他

第9章 世界の脳腫瘍診断および治療市場：最終用途別

• 主な調査結果
• イントロダクション
• 病院
• 腫瘍治療センター
• その他

第10章 世界の脳腫瘍診断および治療市場：地域別

• 主な調査結果
• イントロダクション
  • 脳腫瘍診断および治療市場の評価：地域別、2020年～2034年
• 北米
  • 北米：タイプ別、2020～2034年
  • 北米：製品別、2020～2034年
  • 北米：診断別、2020～2034年
  • 北米：治療別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：タイプ別、2020～2034年
  • 欧州：製品別、2020～2034年
  • 欧州：診断別、2020～2034年
  • 欧州：治療別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：タイプ別、2020～2034年
  • アジア太平洋地域：製品別、2020～2034年
  • アジア太平洋地域：診断別、2020～2034年
  • アジア太平洋地域：治療別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：タイプ別、2020～2034年
  • 中東・アフリカ：製品別、2020～2034年
  • 中東・アフリカ：診断別、2020～2034年
  • 中東・アフリカ：治療別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：タイプ別、2020-2034年
  • ラテンアメリカ：製品別、2020～2034年
  • ラテンアメリカ：診断別、2020～2034年
  • ラテンアメリカ：治療別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第11章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第12章 企業プロファイル

• Bristol Myers Squibb Company
• Canon Medical Systems Corporation
• Carl Zeiss Meditec AG
• GE Healthcare（General Electric Company）
• Hitachi, Ltd.
• Hoffmann-La Roche AG
• Intuitive Surgical, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Siemens Healthineers AG

List of Tables:

• Table 1 Global Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 2 Global Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 3 Global Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 4 Global Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 5 Global Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 6 North America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 7 North America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 8 North America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 9 North America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 10 North America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 11 U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 12 U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 13 U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 14 U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 15 U.S.: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 16 Canada: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 17 Canada: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 18 Canada: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 19 Canada: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 20 Canada: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 21 Europe: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 22 Europe: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 23 Europe: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 24 Europe: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 25 Europe: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 26 UK: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 27 UK: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 28 UK: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 29 UK: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 30 UK: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 31 France: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 32 France: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 33 France: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 34 France: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 35 France: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 36 Germany: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 37 Germany: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 38 Germany: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 39 Germany: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 40 Germany: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 41 Italy: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 42 Italy: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 43 Italy: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 44 Italy: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 45 Italy: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 46 Spain: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 47 Spain: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 48 Spain: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 49 Spain: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 50 Spain: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 51 Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 52 Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 53 Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 54 Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 55 Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 56 Russia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 57 Russia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 58 Russia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 59 Russia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 60 Russia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 61 Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 62 Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 63 Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 64 Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 65 Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 66 Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 67 Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 68 Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 69 Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 70 Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 71 China: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 72 China: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 73 China: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 74 China: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 75 China: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 76 India: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 77 India: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 78 India: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 79 India: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 80 India: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 81 Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 82 Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 83 Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 84 Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 85 Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 86 Japan: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 87 Japan: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 88 Japan: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 89 Japan: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 90 Japan: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 91 Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 92 Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 93 Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 94 Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 95 Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 96 South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 97 South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 98 South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 99 South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 100 South Korea: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 101 Australia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 102 Australia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 103 Australia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 104 Australia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 105 Australia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 106 Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 107 Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 108 Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 109 Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 110 Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 111 Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 112 Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 113 Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 114 Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 115 Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 116 Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 117 Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 118 Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 119 Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 120 Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 121 UAE: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 122 UAE: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 123 UAE: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 124 UAE: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 125 UAE: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 126 Israel: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 127 Israel: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 128 Israel: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 129 Israel: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 130 Israel: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 131 South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 132 South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 133 South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 134 South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 135 South Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 136 Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 137 Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 138 Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 139 Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 140 Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 141 Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 142 Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 143 Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 144 Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 145 Latin America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 146 Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 147 Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 148 Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 149 Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 150 Mexico: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 151 Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 152 Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 153 Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 154 Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 155 Brazil: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 156 Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 157 Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 158 Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 159 Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 160 Argentina: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• Table 161 Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• Table 162 Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• Table 163 Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• Table 164 Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• Table 165 Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Global Brain Tumor Diagnosis and Therapeutics Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Type
• Figure 7. Global Brain Tumor Diagnosis and Therapeutics Market, by Type, 2024 & 2034 (USD Million)
• Figure 8. Market by Product
• Figure 9. Global Brain Tumor Diagnosis and Therapeutics Market, by Product, 2024 & 2034 (USD Million)
• Figure 10. Market by Diagnosis
• Figure 11. Global Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2024 & 2034 (USD Million)
• Figure 12. Market by Therapeutics
• Figure 13. Global Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2024 & 2034 (USD Million)
• Figure 14. Market by End Use
• Figure 15. Global Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2024 & 2034 (USD Million)

The global brain tumor diagnosis and therapeutics market size is expected to reach USD 6,509.72 million by 2034, according to a new study by Polaris Market Research. The report "Brain Tumor Diagnosis and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Primary and Secondary), Product, Diagnosis, Therapeutics, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The brain tumor diagnosis and therapeutics market centers on the development and deployment of medical technologies and pharmaceutical interventions aimed at the identification and treatment of neoplastic growths within the brain. This market is driven by the imperative to address the complex diagnostic and therapeutic challenges posed by brain tumors, which range from benign to highly malignant. It involves a multifaceted approach, integrating advanced imaging techniques, sophisticated laboratory diagnostics, and innovative treatment modalities to improve patient outcomes and quality of life. The market encompasses a broad spectrum of products and services, including neuroimaging equipment, molecular diagnostic tools, surgical devices, radiation therapy systems, and pharmaceutical therapies, reflecting the diverse needs of patients and healthcare providers.

An analysis of this market reveals a landscape characterized by rapid technological advancements and evolving treatment paradigms. The increasing prevalence of brain tumors, coupled with the growing geriatric population, is a significant market driver. Ongoing research and development efforts are focused on enhancing diagnostic accuracy, developing targeted therapies, and improving patient survival rates. The adoption of personalized medicine approaches, driven by advancements in genomics and proteomics, is transforming treatment strategies. Furthermore, the integration of artificial intelligence and machine learning in diagnostic imaging and data analysis is enhancing the efficiency and precision of clinical decision-making. The brain tumor diagnosis and therapeutics market is poised for continued growth, driven by the relentless pursuit of innovative solutions to combat these challenging diseases.

Brain Tumor Diagnosis and Therapeutics Market Report Highlights

By type, the primary segment holds the largest market share, driven by the higher incidence of tumors like gliomas and meningiomas, necessitating extensive diagnostic and therapeutic interventions.

By product, the stains & varnishes segment commands the largest market share due to its essential role in histological and immunohistochemical procedures critical for brain tumor diagnosis and classification.

Based on diagnosis, the MRI segment leads the market, attributed to its non-invasive nature and superior high-resolution imaging capabilities, crucial for precise tumor localization and characterization.

By therapeutics, the surgery segment maintains the largest market share, owing to its fundamental role in tumor removal, particularly for accessible and well-defined tumors, which remains a primary intervention strategy.

Based on end use, the hospitals segment holds the largest market share, driven by their comprehensive care offerings, encompassing a wide range of diagnostic and therapeutic services under one roof, making them primary care providers.

By region, North America holds the largest share of the global market owing to its well-established healthcare infrastructure and high prevalence of brain tumors. Asia Pacific is experiencing the highest growth rate due to the increasing geriatric population, rising awareness of brain tumors, and improving healthcare access.

Key players operating within the market include Hoffmann-La Roche AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Bristol Myers Squibb Company, Siemens Healthineers AG, GE Healthcare (General Electric Company), Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Intuitive Surgical, Inc., and Hitachi, Ltd.

Polaris Market Research has segmented the brain tumor diagnosis and therapeutics market report on the basis of type, product, diagnosis, therapeutics, end use, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

Primary

Secondary

By Product Outlook (Revenue - USD Million, 2020-2034)

Stains & Varnishes

Shellacs

Lacquers

Others

By Diagnosis Outlook (Revenue - USD Million, 2020-2034)

MRI

CT Scan

Tissue Sampling

PET-CT scan

Cerebral Arteriogram

Lumbar Puncture

Molecular Testing

EEG

Others

By Therapeutics Outlook (Revenue - USD Million, 2020-2034)

Surgery

Radiation Therapy

Chemotherapy

Immunotherapy

Targeted Therapy

Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals

Oncology Treatment Centers

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Brain Tumor Diagnosis and Therapeutics Market Insights

• 4.1. Brain Tumor Diagnosis and Therapeutics Market - Frequency Snapshot
• 4.2. Brain Tumor Diagnosis and Therapeutics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Advancements in Neuroimaging Technologies
    • 4.2.1.2. Increasing Prevalence of Brain Tumors and Aging Population
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Difficulty in early detection
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Brain Tumor Diagnosis and Therapeutics Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Brain Tumor Diagnosis and Therapeutics Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
• 5.3. Primary
  • 5.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, Primary, by Region, 2020-2034 (USD Million)
• 5.4. Secondary
  • 5.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Secondary, by Region, 2020-2034 (USD Million)

6. Global Brain Tumor Diagnosis and Therapeutics Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
• 6.3. Stains & Varnishes
  • 6.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Stains & Varnishes, by Region, 2020-2034 (USD Million)
• 6.4. Shellacs
  • 6.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Shellacs, by Region, 2020-2034 (USD Million)
• 6.5. Lacquers
  • 6.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Lacquers, by Region, 2020-2034 (USD Million)
• 6.6. Others
  • 6.6.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
• 7.3. MRI
  • 7.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, MRI, by Region, 2020-2034 (USD Million)
• 7.4. CT Scan
  • 7.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, CT Scan, by Region, 2020-2034 (USD Million)
• 7.5. Tissue Sampling
  • 7.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, Tissue Sampling, by Region, 2020-2034 (USD Million)
• 7.6. PET-CT scan
  • 7.6.1. Global Brain Tumor Diagnosis and Therapeutics Market, PET-CT scan, by Region, 2020-2034 (USD Million)
• 7.7. Cerebral Arteriogram
  • 7.7.1. Global Brain Tumor Diagnosis and Therapeutics Market, Cerebral Arteriogram, by Region, 2020-2034 (USD Million)
• 7.8. Lumbar Puncture
  • 7.8.1. Global Brain Tumor Diagnosis and Therapeutics Market, Lumbar Puncture, by Region, 2020-2034 (USD Million)
• 7.9. Molecular Testing
  • 7.9.1. Global Brain Tumor Diagnosis and Therapeutics Market, Molecular Testing, by Region, 2020-2034 (USD Million)
• 7.10. EEG
  • 7.10.1. Global Brain Tumor Diagnosis and Therapeutics Market, EEG, by Region, 2020-2034 (USD Million)
• 7.11. Others
  • 7.11.1. Global Brain Tumor Diagnosis and Therapeutics Market, Others, by Region, 2020-2034 (USD Million)

8. Global Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
• 8.3. Surgery
  • 8.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Surgery, by Region, 2020-2034 (USD Million)
• 8.4. Radiation Therapy
  • 8.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Radiation Therapy, by Region, 2020-2034 (USD Million)
• 8.5. Chemotherapy
  • 8.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
• 8.6. Immunotherapy
  • 8.6.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Immunotherapy, by Region, 2020-2034 (USD Million)
• 8.7. Targeted Therapy
  • 8.7.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Targeted Therapy, by Region, 2020-2034 (USD Million)
• 8.8. Others
  • 8.8.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Brain Tumor Diagnosis and Therapeutics Market, by End Use

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• 9.3. Hospitals
  • 9.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Hospitals, by Region, 2020-2034 (USD Million)
• 9.4. Oncology Treatment Centers
  • 9.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Oncology Treatment Centers, by Region, 2020-2034 (USD Million)
• 9.5. Others
  • 9.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Others, by Region, 2020-2034 (USD Million)

10. Global Brain Tumor Diagnosis and Therapeutics Market, by Geography

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Brain Tumor Diagnosis and Therapeutics Market Assessment, By Geography, 2020-2034 (USD Million)
• 10.3. Brain Tumor Diagnosis and Therapeutics Market - North America
  • 10.3.1. North America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
  • 10.3.2. North America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
  • 10.3.3. North America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
  • 10.3.4. North America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
  • 10.3.5. North America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.3.7. Brain Tumor Diagnosis and Therapeutics Market - U.S.
    • 10.3.7.1. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.3.7.2. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.3.7.3. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.3.7.4. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.3.7.5. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.3.8. Brain Tumor Diagnosis and Therapeutics Market - Canada
    • 10.3.8.1. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.3.8.2. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.3.8.3. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.3.8.4. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.3.8.5. Canada: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• 10.4. Brain Tumor Diagnosis and Therapeutics Market - Europe
  • 10.4.1. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
  • 10.4.2. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
  • 10.4.3. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
  • 10.4.4. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
  • 10.4.5. Europe: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.6. Brain Tumor Diagnosis and Therapeutics Market - UK
    • 10.4.6.1. UK: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.6.2. UK: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.6.3. UK: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.6.4. UK: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.6.5. UK: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.7. Brain Tumor Diagnosis and Therapeutics Market - France
    • 10.4.7.1. France: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.7.2. France: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.7.3. France: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.7.4. France: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.7.5. France: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.8. Brain Tumor Diagnosis and Therapeutics Market - Germany
    • 10.4.8.1. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.8.2. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.8.3. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.8.4. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.8.5. Germany: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.9. Brain Tumor Diagnosis and Therapeutics Market - Italy
    • 10.4.9.1. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.9.2. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.9.3. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.9.4. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.9.5. Italy: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.10. Brain Tumor Diagnosis and Therapeutics Market - Spain
    • 10.4.10.1. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.10.2. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.10.3. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.10.4. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.10.5. Spain: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.11. Brain Tumor Diagnosis and Therapeutics Market - Netherlands
    • 10.4.11.1. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.11.2. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.11.3. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.11.4. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.11.5. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.12. Brain Tumor Diagnosis and Therapeutics Market - Russia
    • 10.4.12.1. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.12.2. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.12.3. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.12.4. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.12.5. Russia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.4.13. Brain Tumor Diagnosis and Therapeutics Market - Rest of Europe
    • 10.4.13.1. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.4.13.2. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.4.13.3. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.4.13.4. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.4.13.5. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• 10.5. Brain Tumor Diagnosis and Therapeutics Market - Asia Pacific
  • 10.5.1. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
  • 10.5.2. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
  • 10.5.3. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
  • 10.5.4. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
  • 10.5.5. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.6. Brain Tumor Diagnosis and Therapeutics Market - China
    • 10.5.6.1. China: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.6.2. China: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.6.3. China: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.6.4. China: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.6.5. China: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.7. Brain Tumor Diagnosis and Therapeutics Market - India
    • 10.5.7.1. India: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.7.2. India: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.7.3. India: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.7.4. India: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.7.5. India: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.8. Brain Tumor Diagnosis and Therapeutics Market - Malaysia
    • 10.5.8.1. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.8.2. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.8.3. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.8.4. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.8.5. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.9. Brain Tumor Diagnosis and Therapeutics Market - Japan
    • 10.5.9.1. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.9.2. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.9.3. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.9.4. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.9.5. Japan: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.10. Brain Tumor Diagnosis and Therapeutics Market - Indonesia
    • 10.5.10.1. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.10.2. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.10.3. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.10.4. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.10.5. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.11. Brain Tumor Diagnosis and Therapeutics Market - South Korea
    • 10.5.11.1. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.11.2. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.11.3. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.11.4. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.11.5. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.12. Brain Tumor Diagnosis and Therapeutics Market - Australia
    • 10.5.12.1. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.12.2. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.12.3. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.12.4. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.12.5. Australia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.5.13. Brain Tumor Diagnosis and Therapeutics Market - Rest of Asia Pacific
    • 10.5.13.1. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.5.13.2. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.5.13.3. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.5.13.4. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.5.13.5. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• 10.6. Brain Tumor Diagnosis and Therapeutics Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
  • 10.6.2. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
  • 10.6.3. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
  • 10.6.4. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
  • 10.6.5. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.6. Brain Tumor Diagnosis and Therapeutics Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.6.6.2. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.6.6.3. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.6.6.4. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.6.6.5. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.7. Brain Tumor Diagnosis and Therapeutics Market - UAE
    • 10.6.7.1. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.6.7.2. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.6.7.3. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.6.7.4. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.6.7.5. UAE: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.8. Brain Tumor Diagnosis and Therapeutics Market - Israel
    • 10.6.8.1. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.6.8.2. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.6.8.3. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.6.8.4. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.6.8.5. Israel: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.9. Brain Tumor Diagnosis and Therapeutics Market - South Africa
    • 10.6.9.1. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.6.9.2. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.6.9.3. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.6.9.4. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.6.9.5. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.6.10. Brain Tumor Diagnosis and Therapeutics Market - Rest of Middle East & Africa
    • 10.6.10.1. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.6.10.2. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.6.10.3. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.6.10.4. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.6.10.5. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
• 10.7. Brain Tumor Diagnosis and Therapeutics Market - Latin America
  • 10.7.1. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
  • 10.7.2. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
  • 10.7.3. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
  • 10.7.4. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
  • 10.7.5. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.6. Brain Tumor Diagnosis and Therapeutics Market - Mexico
    • 10.7.6.1. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.7.6.2. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.7.6.3. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.7.6.4. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.7.6.5. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.7. Brain Tumor Diagnosis and Therapeutics Market - Brazil
    • 10.7.7.1. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.7.7.2. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.7.7.3. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.7.7.4. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.7.7.5. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.8. Brain Tumor Diagnosis and Therapeutics Market - Argentina
    • 10.7.8.1. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.7.8.2. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.7.8.3. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.7.8.4. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.7.8.5. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
  • 10.7.9. Brain Tumor Diagnosis and Therapeutics Market - Rest of Latin America
    • 10.7.9.1. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
    • 10.7.9.2. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
    • 10.7.9.3. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
    • 10.7.9.4. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
    • 10.7.9.5. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. Bristol Myers Squibb Company
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Canon Medical Systems Corporation
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. Carl Zeiss Meditec AG
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. GE Healthcare (General Electric Company)
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. Hitachi, Ltd.
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. Hoffmann-La Roche AG
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Benchmarking
  • 12.6.4. Recent Development
• 12.7. Intuitive Surgical, Inc.
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Benchmarking
  • 12.7.4. Recent Development
• 12.8. Merck & Co., Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Benchmarking
  • 12.8.4. Recent Development
• 12.9. Novartis AG
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Benchmarking
  • 12.9.4. Recent Development
• 12.10. Pfizer Inc.
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Benchmarking
  • 12.10.4. Recent Development
• 12.11. Siemens Healthineers AG
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Benchmarking
  • 12.11.4. Recent Development